<DOC>
	<DOCNO>NCT02371759</DOCNO>
	<brief_summary>The purpose study determine whether 2 % lidocaine ( L ) + clonidine ( C ) ( 15 mcg/ml ) vasoconstrictor achieve efficient ( equal good parameter intraoral local anesthesia comparison 2 % lidocaine + epinephrine ( E ) ( 1:80 000 ) ) safe ( stable cardiovascular parameter - systolic , diastolic , mean blood pressure heart rate ) intraoral local anesthesia patient Diabetes mellitus type 2 .</brief_summary>
	<brief_title>Lidocaine + Clonidine Intraoral Anesthesia Patients With Diabetes Mellitus Type 2</brief_title>
	<detailed_description>Patients diabetes mellitus type 2 , represent risk perform regional anesthesia technique due microvascular ( microangiopathy , neuropathy ) macrovascular ( hypertension , coronary heart disease ) complication . There evidence local anesthetic toxicity may increase diabetic setting due underlie neuropathy ; interaction diabetic blood vessel vasoconstrictor may importance microangiopathic change . Lately , regional anesthesia protocol general surgery patient diabetes mellitus release , propose reduction local anesthetic concentration avoid epinephrine vasoconstrictor . Oral cavity tissue diabetes mellitus also suffer neuropathy ( burn , paresthesia , teeth loss , temporomandibular dysfunction , xerostomia ) microangiopathy ( periodontal disease , salivary gland dysfunction ) . Most widely use vasoconstrictor intraoral local anesthesia , epinephrine , alpha- beta- adrenergic agonist . Because beta-adrenergic effect , epinephrine could adversely affect cardiovascular function , especially risk patient . There data suggest intraoral local anesthesia obtain 2 % lidocaine clonidine , selective alpha 2-adrenoceptor agonist vasoconstrictor , characterize significantly stable cardiovascular parameter similar parameter local anesthesia respect lidocaine epinephrine healthy hypertensive patient . With regard aforementioned , aim randomize double-blind control clinical trial evaluate compare efficacy safety intraoral local anesthesia obtain 2 % lidocaine ( L ) + clonidine ( 15 mcg/ml ) ( C ) 2 % L + epinephrine ( 1:80 000 ) ( E ) , compare healthy diabetes mellitus type 2 patient . Prior tooth extraction , random allocation one four group ( L+C maxillary infiltration , L+C mandibular block , L+E maxillary infiltration L+E mandibular block ) perform diabetic ( 30 per group ) healthy ( 30 per group ) patient . Parameters local anesthesia ( onset , duration , intensity , width anesthetic field maxillary infiltration ) , cardiovascular parameter ( systolic , diastolic , mean arterial pressure ; heart rate electrocardiographic change ) , quality postoperative analgesia ( assessed Visual Analogue Scale , Numerical Rating Scale number consume analgesic ) postoperative complication ( infection , bleeding , paresthesia , delay wound heal ) evaluate compare .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Healthy participant : ASA I Diabetic type 2 participant : ASA III ( HbA1c level &lt; 9 % ) Required singleroot teeth indicate noncomplicated extraction Dental diagnosis periodontal disease , tooth fracture , chronic periapical lesion root infection Subjects give inform write consent Pregnancy lactation Allergy use drug food Hepatic and/or renal failure ASA IV patient Tobacco smoker History alcoholism and/or drug abuse addiction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>